These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2543996)

  • 1. Endorphins in male impotence: evidence for naltrexone stimulation of erectile activity in patient therapy.
    Fabbri A; Jannini EA; Gnessi L; Moretti C; Ulisse S; Franzese A; Lazzari R; Fraioli F; Frajese G; Isidori A
    Psychoneuroendocrinology; 1989; 14(1-2):103-11. PubMed ID: 2543996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of idiopathic erectile dysfunction in men with the opiate antagonist naltrexone--a double-blind study.
    Brennemann W; Stitz B; Van Ahlen H; Brensing KA; Klingmüller D
    J Androl; 1993; 14(6):407-10. PubMed ID: 8294223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of daily intake of apomorphine SL in men affected by erectile dysfunction and mild hyperprolactinemia: a prospective, open-label, pilot study.
    Caruso S; Intelisano G; Farina M; DiMari L; Agnello C; Giammusso B
    Urology; 2003 Nov; 62(5):922-7. PubMed ID: 14624921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles.
    Cooper AJ; Sandhu S; Losztyn S; Cernovsky Z
    Can J Psychiatry; 1992 Dec; 37(10):687-93. PubMed ID: 1473073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of erectile impotence in renal transplant patients with intracavernosal vasoactive drugs.
    Rodriguez Antolin A; Morales JM; Andrés A; Fernández Aparicio T; Díaz González R; Pamplona M; Alvarez E
    Transplant Proc; 1992 Feb; 24(1):105-6. PubMed ID: 1539195
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and hormonal effects of testosterone undecanoate (TU) in male sexual impotence.
    Klepsch I; Măicănescu-Georgescu M; Marinescu L
    Endocrinologie; 1982; 20(4):289-93. PubMed ID: 6818673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erectile impotence in chronic alcoholics.
    Tan ET; Johnson RH; Lambie DG; Vijayasenan ME; Whiteside EA
    Alcohol Clin Exp Res; 1984; 8(3):297-301. PubMed ID: 6430115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Male diabetic sexual impotence: effects of dopaminergic agents.
    Pierini AA; Nusimovich B
    Arch Androl; 1981 Jun; 6(4):347-50. PubMed ID: 6788008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic-hypophyseal-testicular abnormalities and erectile dysfunction.
    Shah RS; Pardanani DS; Parulkar BG; Purohit SP; Bandivdekar AH; Sheth AR
    Arch Androl; 1988; 20(2):137-40. PubMed ID: 3134861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of uraemic impotence by zinc.
    Antoniou LD; Shalhoub RJ; Sudhakar T; Smith JC
    Lancet; 1977 Oct; 2(8044):895-8. PubMed ID: 72240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sexual dysfunction and erectile impotence in chronic obstructive pulmonary disease.
    Fletcher EC; Martin RJ
    Chest; 1982 Apr; 81(4):413-21. PubMed ID: 6802573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intravenously administered human chorionic gonadotrophin on plasma testosterone in patients with sexual impotence and oligozoospermia.
    Krause W
    Int J Androl; 1980 Jun; 3(3):251-5. PubMed ID: 6773892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of sexual impotence in male patients with chronic obstructive pulmonary disease and hypoxemia with long-term oxygen therapy.
    Aasebø U; Gyltnes A; Bremnes RM; Aakvaag A; Slørdal L
    J Steroid Biochem Mol Biol; 1993 Dec; 46(6):799-803. PubMed ID: 8274414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible hypothalamic impotence. Male counterpart to hypothalamic amenorrhea?
    Guay AT; Bansal S; Hodge MB
    Urology; 1991 Oct; 38(4):317-22. PubMed ID: 1755138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies.
    Chatterjee R; Kottaridis PD; McGarrigle HH; Linch DC
    Bone Marrow Transplant; 2002 Apr; 29(7):607-10. PubMed ID: 11979311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
    J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced 'gonadotrophin response to releasing hormone' after chronic administration to impotent men.
    Davies TF; Gomez-Pan A; Watson MJ; Mountjoy CQ; Hanker JP; Besser GM; Hall R
    Clin Endocrinol (Oxf); 1977 Mar; 6(3):213-8. PubMed ID: 322894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of erection: does it really matter? A randomized, double-blind clinical trial to assess the impact of vardenafil ODT on duration of erection and its correlation with patients' and partners' sexual quality of life and duration of intercourse: the VADEOPEN study.
    Martin-Morales A; Gutiérrez-Hernández P; Romero-Otero J; Romero-Martín JA;
    J Sex Med; 2014 Jun; 11(6):1527-38. PubMed ID: 24628736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual functioning in testosterone-supplemented patients treated for bilateral testicular cancer.
    van Basten JP; van Driel MF; Jonker-Pool G; Sleijfer DT; Schraffordt Koops H; van de Wiel HB; Hoekstra HJ
    Br J Urol; 1997 Mar; 79(3):461-7. PubMed ID: 9117232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate use and sexual function.
    Mirin SM; Meyer RE; Mendelson JH; Ellingboe J
    Am J Psychiatry; 1980 Aug; 137(8):909-15. PubMed ID: 6774622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.